Lv1
10 积分 2021-03-24 加入
存活肿瘤细胞比例在初始不可切除肝细胞癌患者转化序贯外科治疗预后评估中的应用
1天前
待确认
Updated results of anlotinib combined with TQB2450 (PD-L1 blockade) as first-line treatment for advanced esophageal squamous cell carcinoma (ESCC): A single-arm, multicenter, open-label phase Ⅱ clinical trial
25天前
已完结
MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
1年前
已完结
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial
1年前
已完结
ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer
1年前
已关闭
Advances in clinical immunotherapy for gastric cancer
1年前
已完结
The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer
1年前
已完结
PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
1年前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1年前
已完结
Mass spectra of partially n-acetylated derivatives of kanamycin a
4年前
已完结
皖公网安备34019202002308
